Roche to acquire Spark Therapeutics for $ 4.3B

World |  News | 0 Comment | 25 Feb, 2019

Roche and Spark Therapeutics have entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of US$ 114.50 per share in an all-cash transaction. Thi...Read more

AbbVie and Voyager Therapeutics announce collaboration

World |  News | 0 Comment | 25 Feb, 2019

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases has announc...Read more

FDA grants priority review to Merck’s application for KEYTRUDA in SCLC

World |  News | 0 Comment | 22 Feb, 2019

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) for KEYTRUDA, Merck&rsq...Read more

Teva to apply Insilico’s predictive Digital Twins for biopharmaceutical production

World |  News | 0 Comment | 22 Feb, 2019

Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. have announced an agreement to apply Insilico’s technology for predictive biomanufacturing to create and implement mo...Read more

WHO releases report on Global Health Expenditure

World |  News | 0 Comment | 22 Feb, 2019

Spending on health is growing faster than the rest of the global economy, accounting for 10% of global gross domestic product (GDP). A new report on global health expenditure from...Read more

Merck to acquire Immune Design in a $300M deal

World |  News | 0 Comment | 22 Feb, 2019

Merck , known as MSD outside the United States and Canada, and Immune Design, has announced that the companies have entered into a definitive agreement under which Merck, through a subsidia...Read more

Mallinckrodt presents analysis results for Therakos against aGvHD

World |  News | 0 Comment | 21 Feb, 2019

Mallinckrodt plc, a leading global specialty pharmaceutical company has announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study asse...Read more

Takeda, Microsoft, EURORDIS release action plan to end the diagnostic odyssey

World |  News | 0 Comment | 21 Feb, 2019

The Global Commission to End the Diagnostic Odyssey for Children , co-chaired by Takeda, Microsoft and EURORDIS-Rare Diseases Europe, an alliance of more than 800 rare disease patient organ...Read more

Aveanna Healthcare to acquire Maxim Healthcare Services' Home Healthcare Division

World |  News | 0 Comment | 20 Feb, 2019

Aveanna Healthcare, a leading home healthcare company has announced that it has entered into a definitive agreement to acquire the home healthcare division of Maxim Healthcare Services. Max...Read more

AGC Biologics, Calypso Biotech sign pact for cGMP manufacturing

World |  News | 0 Comment | 21 Feb, 2019

AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and Calypso Biotech B.V. (Calypso), a biotechnology company focused on the development of no...Read more

Novartis receives FDA approval for Egaten

World |  News | 0 Comment | 20 Feb, 2019

Novartis has announced that the US Food and Drug Administration (FDA) approval of Egaten (triclabendazole) for the treatment of fascioliasis in patients six years of age and older. This mak...Read more

Merck gets first U.S. Patent for improved CRISPR technology

World |  News | 0 Comment | 20 Feb, 2019

Merck, a leading science and technology company and leader in genome editing, announced that the United States Patent and Trademark Office has issued a formal notice allowing Merck's p...Read more

Qiagen to advance fight against antibiotic resistant pathogens

World |  News | 0 Comment | 20 Feb, 2019

QIAGEN N.V. has announced a broad agreement with Ares Genetics, a subsidiary of Curetis N.V., to develop innovative bioinformatics and assay solutions to accelerate research targeting the g...Read more

FDA & NIH-funded study finds genetic vulnerability to menthol cigarette use

World |  News | 0 Comment | 19 Feb, 2019

A genetic variant found only in people of African descent significantly increases a smoker’s preference for cigarettes containing menthol, a flavor additive. The variant of the M...Read more

Saniona announces succesful completion of preclinical development of SAN711

World |  News | 0 Comment | 19 Feb, 2019

Saniona, a biotech company focused on CNS and eating disorders has announced the successful completion of preclinical development of SAN711, for the treatment of chronic itching and neuropa...Read more

Healthcare Artificial Intelligence market to hit $13B by 2025

World |  News | 0 Comment | 19 Feb, 2019

Europe healthcare artificial intelligence market witnessed 41.8% growth throughout the analysis period. Adoption of artificial intelligence in research areas and advancement in technol...Read more

WHO-ITU standard to prevent hearing loss among 1.1 billion young people

World |  News | 0 Comment | 19 Feb, 2019

Ahead of World Hearing Day (3 March), the World Health Organization (WHO) and the International Telecommunication Union (ITU) have issued a new international standard for the manufacture an...Read more

Quest Diagnostics names Gabrielle Wolfson as Sr. VP and Chief Information and Digital Officer

World |  News | 0 Comment | 19 Feb, 2019

Quest Diagnostics, the world's leading provider of diagnostic information services has announced that Gabrielle Wolfson, a veteran information technology business leader, has been name...Read more